Carl Zeiss Meditec (OTCMKTS:CZMWY) Shares Gap Down – Time to Sell?

Carl Zeiss Meditec AG (OTCMKTS:CZMWY)’s share price gapped down prior to trading on Monday. The stock had previously closed at $40.23, but opened at $38.29. Carl Zeiss Meditec shares last traded at $38.21, with a volume of 212 shares.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. UBS Group downgraded Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research report on Tuesday, August 11th. Zacks Research upgraded Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 6th. Morgan Stanley initiated coverage on Carl Zeiss Meditec in a research report on Wednesday, September 2nd. They set an “underweight” rating on the stock. Finally, The Goldman Sachs Group downgraded Carl Zeiss Meditec from a “hold” rating to a “sell” rating in a research note on Monday, October 5th. Two research analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Strong Sell”.

Carl Zeiss Meditec Stock Performance

The business’s 50 day moving average is $36.68 and its two-hundred day moving average is $32.88.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a medical technology company headquartered in Jena, Germany, and part of the ZEISS Group. The company develops, manufactures and distributes equipment and solutions for ophthalmology and microsurgery, serving hospitals, clinics and medical professionals worldwide. Its ophthalmic portfolio includes diagnostic systems for examining the eye, equipment for cataract and refractive surgery, surgical lasers, intraocular lenses and other related products. The company also supplies surgical microscopes, visualization systems and digital technologies used in neurosurgery, spine surgery, ear, nose and throat procedures, and other microsurgical specialties.